Skip to content

Redefining Photosensitizers Functionality Through Consensus-Assisted Integration of Orthogonal Antibacterial Mechanisms.

Sep 2026 · Angewandte Chemie · pp. e2546246 · 0 citations · 44 references
Medicine

TL;DR

This work helps to transform PSs from ROS-dependent killing agents into therapeutics with orthogonal antibacterial mechanisms, establishing a proof-of-concept for a generalizable PSs design paradigm.

Abstract

Photodynamic antimicrobial therapy (PDAT) offers a promising bactericidal strategy via light-triggered reactive oxygen species (ROS), yet conventional photosensitizers (PSs) typically lack sustained inhibitory activity. Herein, we attempt to redefine the functionality of PSs through a consensus-assisted design strategy that integrates deep learning and molecular docking to embed orthogonal antibacterial mechanisms into a single PS molecule. Specifically, a near-infrared hemi-cyanine PS IHcy-OH is found to unite PDAT with interference of filamentous temperature-sensitive mutant Z (FtsZ) protein, which is essential for bacterial division. By conjugating IHcy-OH with a responsive arm, IHcy-PbE is rationally designed and synthesized to achieve infection responsiveness, rapid light-controlled bactericidal activity, and long-time bacterial inhibition. While such integration typically requires complex multi-component platforms, this strategy successfully unlocks the multifunctional potential of a single PS molecule. Consistent with its design, IHcy-PbE could inhibit methicillin-resistant S. aureus (MRSA) in the dark and exert robust PDAT efficacy upon exposure to hydrogen peroxide and light. This work helps to transform PSs from ROS-dependent killing agents into therapeutics with orthogonal antibacterial mechanisms, establishing a proof-of-concept for a generalizable PSs design paradigm.

View source

Similar papers

Review Sep 2026

Covalent Organic Frameworks as Next-Generation Photosensitizers: Mechanistic Underpinnings and Emerging Advances in Antimicrobial Photodynamic Therapy.

This review examines COF-based aPDT from a structure-photophysics-ROS-biological response perspective and discusses the structural identity of COF-based platforms, core photodynamic mechanisms, photoactive building blocks, and enhancement strategies including metal coupling, targeting engineering, responsive release, p...

Ming-Can Zhao, Yuan-Dong Xie, Zhen-Yu Ma et al. · 0 citations
Review Open access

Research advances in metal-complex-based photosensitizers for photodynamic antimicrobial therapy

This review highlights the great potential of metal complex-based photosensitizers as next-generation antibacterial agents, and underscores that rational molecular design combined with optimized delivery systems and irradiation strategies will accelerate their clinical translation from laboratory research to clinical p...

Yi-Meng Wang, Jin-Hui Zhou, Xu-Zhe Lin et al. · 0 citations
Sep 2026

Boron subphthalocyanine aggregates enable antimicrobial photodynamic therapy against antibiotic-resistant bacteria in nanomolar concentrations

Evaluating how axial versus peripheral fluorination within a BsubPc scaffold impacts aqueous behavior, photoreactivity, and aPDT performance positions BsubPcs as a compact, formulation-minimal platform for aPDT against drug-resistant bacteria.

Nahyun Kwon, Caitlyn Lee, Alicia Voge et al. · 0 citations
Review Open access Sep 2026

Recent Advances in Zinc(II)-Complexes for Antibacterial Photodynamic Therapy.

This review critically examines recent advances in Zn(II)-based complexes as photosensitizers, including phthalocyanines, porphyrins, chlorins, and curcumin systems, highlighting structure-activity relationships (SARs), ROS generation mechanisms, and antibacterial efficacy against both Gram-positive and Gram-negative p...

R. Kushwaha, Samya Banerjee · 0 citations
Aug 2026

Aggregation-induced BODIPY photosensitizers for synergistic type I/II photodynamic antibacterial therapy.

These heavy-atom-free BODIPY photosensitizers integrate AIE, Type I/II aPDT activity, and in vivo wound-healing performance against MRSA, thus successfully addressing the major limitations of conventional BODIPY photosensitizers.

De-Chao Yang, Hang Zhu, Chang-Ying Wu et al. · 0 citations
Review Aug 2026

Organic photosensitizers for antifungal therapy: structural diversity and emerging applications.

This review critically compares natural product-derived photosensitizers, cyanine dyes, porphyrinoids, BODIPYs, aggregation-induced emission luminogens, and emerging molecular platforms for antifungal aPDT to establish how molecular design governs antifungal performance.

Wei-Xuan He, Zi-Hao Liang, Hongshan Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.